High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer

Abstract

Alpha-methylacyl-CoA racemase (AMACR) is a well-characterized marker extensively utilized in prostate cancer (PCA) diagnosis. However, the prognostic value of AMACR expression and its relation to TMPRSS2-ERG gene rearrangement as one of the most common molecular alterations in PCA is not fully explored. AMACR expression was investigated in a cohort of 218… (More)
DOI: 10.1007/s13277-016-5075-1

Topics

9 Figures and Tables

Cite this paper

@article{Box2016HighAR, title={High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer}, author={Adrian Harold Box and Mohammed Alshalalfa and Samar A. Hegazy and Bryan Donnelly and Tarek A. Bismar}, journal={Tumor Biology}, year={2016}, volume={37}, pages={12287-12299} }